Baxter International (NYSE:BAX – Free Report) had its target price raised by Citigroup from $41.00 to $44.00 in a report published on Wednesday morning, Benzinga reports. Citigroup currently has a neutral rating on the medical instruments supplier’s stock. Several other brokerages have also recently issued reports on BAX. Barclays raised their target price on Baxter […]
Baxter International (NYSE:BAX – Get Free Report) had its price objective increased by stock analysts at Citigroup from $41.00 to $44.00 in a report issued on Wednesday, Benzinga reports. The firm currently has a “neutral” rating on the medical instruments supplier’s stock. Citigroup’s price objective suggests a potential upside of 1.62% from the company’s previous […]
Baxter International (NYSE:BAX – Get Free Report) had its price target boosted by stock analysts at Citigroup from $41.00 to $44.00 in a report issued on Wednesday, Benzinga reports. The firm currently has a “neutral” rating on the medical instruments supplier’s stock. Citigroup’s target price points to a potential upside of 1.62% from the company’s […]
Carmignac Gestion increased its holdings in Baxter International Inc. (NYSE:BAX – Free Report) by 467.0% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 4,848,773 shares of the medical instruments supplier’s stock after purchasing an additional 3,993,537 shares during the period. Baxter […]
BABB (BAX) traded 3.8% higher against the US dollar during the 1-day period ending at 19:00 PM Eastern on March 10th. During the last seven days, BABB has traded up 3.4% against the US dollar. BABB has a market capitalization of $14.70 million and $226,721.35 worth of BABB was traded on exchanges in the last […]